Previous research from our team demonstrated that Mfn2 safeguards against diabetic cardiomyopathy by promoting mitochondrial fusion.[19] However, this study reveals that Mfn2's role in MLC is independent of its promotion of mitochondrial fusion and cannot be substituted by Mfn1. Here, MFN2 is linked to diabetic cardiomyopathy.